MEDIROM Healthcare Technologies
MRM
1 hedge funds and large institutions have $13K invested in MEDIROM Healthcare Technologies in 2022 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
0% more capital invested
Capital invested by funds: $13K → $13K ($0)
0% more ownership
Funds ownership: 0.04% → 0.04% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$44 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $13K | +$44 | +7 | +0.3% |
|
MRM Hedge Fund Activity: Q3 2022 in Review
1 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in MEDIROM Healthcare Technologies (MRM) for Q3 2022, worth a combined $13K — unchanged from a quarter earlier.
Fund positioning in MRM was balanced in Q3 2022: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $44.
- 1 institutional investor held MEDIROM Healthcare Technologies (MRM) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $13K of MEDIROM Healthcare Technologies stock for Q3 2022, unchanged quarter-over-quarter.
- 0 funds opened new MEDIROM Healthcare Technologies positions in Q3 2022 and 0 closed out.
- The largest MEDIROM Healthcare Technologies buyer in Q3 2022 was UBS Group, an estimated $44 added.
Based on aggregated 13F filings for Q3 2022.